Chelsea Therapeutics International Ltd. (CHTP) Stock Quote

Detailed Quote for Chelsea Therapeutics International Ltd. (CHTP) 
$ 4.065   -0.125 (-2.98%) Volume: 28.6 k 10:40 AM EDT Sep 2, 2010
Today 5d 1m 3m 1y more
Last Price
4.065
Change $
0.125
Change %
2.98%
Tick
  
Bid
4.06
Bid Size
1400
Ask
4.08
Ask Size
300
Open
4.17
High
4.17
Low
4.02
Prev Close
4.19
Last Trade
10:40
Volume
28.6 k
52 Wk Hi
7.51
52 Wk Low
1.71
Market Cap
163.41 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
40,200,406
EPS (TTM)
-0.83
PE Ratio
N/A
Exchange
NSC
News and Media for Chelsea Therapeutics International Ltd.  (CHTP) 
Sector News | Topic News
News for CHTP
Thu, Aug 26, 2010
7:30 AM Chelsea Therapeutics Announces FDA Approval of CH-4051 Phase II Protocol - Globe Newswire
Fri, Aug 20, 2010
12:34 PM Chelsea Therapuetics can capture larger share of the market - Accesswire
12:33 PM Chelsea Therapuetics can capture larger share of the market - Accesswire
Thu, Aug 19, 2010
7:30 AM Chelsea Therapeutics Announces Initiation of Investigator-Led Phase II Study of Droxidopa in Chronic Fatigue Syndrome - Globe Newswire
Tue, Jul 27, 2010
4:09 PM Chelsea Therapeutics Reports Second Quarter 2010 Results - Globe Newswire
Wed, Jul 21, 2010
7:33 AM Chelsea Therapeutics to Host Conference Call to Discuss Second Quarter 2010 Results - Globe Newswire
Thu, Jul 01, 2010
7:46 AM Chelsea Therapeutics Reports Positive Interim Analysis of Phase II Trial of Droxidopa in Fibromyalgia - Globe Newswire
Wed, Jun 30, 2010
7:35 AM Chelsea Therapeutics Achieves Target Enrollment in Phase III Trial of Northera in Neurogenic Orthostatic Hypotension - Globe Newswire
Tue, Jun 29, 2010
1:00 PM Stock-PR.com Announces Daily Stock Watch - World Stock Wire
7:34 AM Chelsea Therapeutics Initiates Northera Study 306 in Neurogenic Orthostatic Hypotension Associated With Parkinson's Disease and Provides Update on Status of Phase II Study of CH-4051 in Rheumatoid Arthritis - Globe Newswire
Tue, Jun 22, 2010
8:08 AM Chelsea Therapeutics to Present at Sidoti Semiannual Micro Cap Conference - Globe Newswire
Thu, Jun 17, 2010
7:33 AM Chelsea Therapeutics Presents Data at 14th International Congress on Parkinson's Disease and Movement Disorders - Globe Newswire
Wed, Jun 09, 2010
6:31 AM Chelsea Therapeutics Announces Update on Antifolate Clinical Program - Globe Newswire
Thu, Jun 03, 2010
8:37 AM Chelsea Therapeutics to Present at 9th Annual Needham Healthcare Conference - Globe Newswire
Tue, May 18, 2010
8:48 AM Chelsea Therapeutics Reports Data From Study 303 Confirming Safety and Robust Therapeutic Benefit of Long-Term Northera Treatment in Neurogenic Orthostatic Hypotension - Globe Newswire
Thu, Apr 29, 2010
4:18 PM Chelsea Therapeutics Reports First Quarter 2010 Results - Globe Newswire
Thu, Apr 22, 2010
8:01 AM Chelsea Therapeutics to Host Conference Call to Discuss First Quarter 2010 Results - Globe Newswire
Tue, Apr 06, 2010
7:31 AM Chelsea Therapeutics to Present at the Future Leaders in the Biotech Industry Conference - Globe Newswire
Wed, Mar 17, 2010
9:03 AM Chelsea Therapeutics Reports Findings From Northera 24-Hour Blood Pressure Monitoring Study - Globe Newswire
Fri, Mar 12, 2010
7:30 AM Chelsea Therapeutics to Present at the ROTH 22nd Annual OC Growth Stock Conference on Wednesday, March 17, 2010 - Globe Newswire
More News for CHTP >>

Tags for Chelsea Therapeutics International Ltd.

Research stocks or mutual funds related to Chelsea Therapeutics International Ltd. by keywords or tags. Find companies that have a similar focus to CHTP. The keywords below have been associated to CHTP by either user submission or electronic means.

chelsea football club tickets barrier turbidity bamboo barrier spode chelsea barrier bag barrier repair chelsea fc screensaver chelsea package abra therapeutics acoustical barrier chelsea mi hotel pex barrier chelsea t shirt amicus therapeutics cv therapeutics chelsea electricians earth therapeutics barrier block water filled barrier Pharmaceutical and Medicine Manufacturing (325410) chelsea hotel dubai radiant barrier vacuum barrier chelsea townhouse cell therapeutics Drugs city chelsea chelsea football tickets umbro chelsea corcept therapeutics chelsea mi hotels barrier therapeutics chelsea screensavers fish barrier chelsea players pet barrier chelsea screensaver therapeutics products the washington manual of medical therapeutics crowd control barrier chelsea clocks Healthcare ark map chelsea table sound barrier walls critical therapeutics chelsea hotel cologne barrier tapes Common Stock therapeutic product

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.